文献速递睡眠呼吸障碍咽喉与嗓音

上气道刺激治疗阻塞性睡眠呼吸暂停:ADHERE登记研究结果

Upper Airway Stimulation for Obstructive Sleep Apnea: Results from the ADHERE Registry.
PubMed 文献 · Otolaryngol Head Neck Surg · 2018-03-20

ADHERE登记研究纳入美、德10家医院301例CPAP不耐受的中重度OSA患者,评估上气道刺激(UAS)疗效。UAS植入后AHI从35.6降至10.2次/小时,ESS从11.9降至7.5(均P<.0001),每晚使用6.5小时,并发症率低,94%医生认为症状改善,90%患者比CPAP更满意。

要点

  • UAS显著降低AHI和ESS,改善客观与主观OSA指标。
  • 患者治疗依从性好,平均每晚使用6.5小时。
  • 手术及设备相关并发症发生率低,患者满意度高。

核心结论

  • UAS治疗可显著改善CPAP不耐受中重度OSA患者的主观和客观结局,依从性好且满意度高。

研究设计与样本

  • 回顾性和前瞻性登记研究,纳入美国和德国10家三级医院301例CPAP不耐受的中重度OSA患者。

主要发现

  • AHI从基线35.6±15.3降至滴定后10.2±12.9次/小时(P<.0001)。
  • Epworth嗜睡量表评分从11.9±5.5降至7.5±4.7(P<.0001)。
  • 患者每晚使用治疗6.5小时。
  • 94%的医生认为患者症状改善,90%的患者对UAS比CPAP更满意。

临床怎么用

  • 对于CPAP不耐受的中重度OSA患者,UAS可作为替代治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective Upper airway stimulation (UAS) is an alternative treatment option for patients unable to tolerate continuous positive airway pressure (CPAP) for the treatment of obstructive sleep apnea (OSA). Studies support the safety and efficacy of this therapy. The aim of this registry is to collect retrospective and prospective objective and subjective outcome measures across multiple institutions in the United States and Germany. To date, it represents the largest cohort of patients studied with this therapy. Study Design Retrospective and prospective registry study. Setting Ten tertiary care hospitals in the United States and Germany. Subjects and Methods Patients were included who had moderate to severe OSA, were intolerant to CPAP, and were undergoing UAS implantation. Baseline demographic and sleep study data were collected. Objective and subjective treatment outcomes, adverse events, and patient and physician satisfaction were reviewed. Results The registry enrolled 301 patients between October 2016 and September 2017. Mean ± SD AHI decreased from 35.6 ± 15.3 to 10.2 ± 12.9 events per hour ( P < .0001), and Epworth Sleepiness Scale scores decreased from 11.9 ± 5.5 to 7.5 ± 4.7 ( P < .0001) from baseline to the posttitration visit. Patients utilized therapy for 6.5 hours per night. There were low rates of procedure- and device-related complications. Clinical global impression scores demonstrated that the majority of physicians (94%) saw improvement in their patients' symptoms with therapy. The majority of patients (90%) were more satisfied with UAS than CPAP. Conclusions Across a multi-institutional registry, UAS therapy demonstrates significant improvement in subjective and objective OSA outcomes, good therapy adherence, and high patient satisfaction.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Boon M, Huntley C, Steffen A, et al. Upper Airway Stimulation for Obstructive Sleep Apnea: Results from the ADHERE Registry. Otolaryngol Head Neck Surg. 2018. PMID: 29557280. doi:10.1177/0194599818764896

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。